AIP Form 4: Director sale of 50,000 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Arteris, Inc. (AIP) — Form 4 insider transaction: On 11/10/2025, a reporting person sold 50,000 shares of common stock at a weighted average price of $14.7366, coded as an open-market sale (S). The sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2025.
Following the transaction, the reporting person beneficially owned 9,639,071 shares, held indirectly through Bayview Legacy, LLC. The filer is identified as a Director. The price range for the sales was $14.34 to $14.95, with details available upon request.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 50,000 shares ($736,830)
Net Sell
1 txn
Insider
Bayview Legacy, LLC
Role
10% Owner
Sold
50,000 shs ($737K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 50,000 | $14.7366 | $737K |
Holdings After Transaction:
Common Stock — 9,639,071 shares (Indirect, See Footnote)
Footnotes (1)
- Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.34 to $14.95 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.
FAQ
What insider transaction did AIP report?
A sale of 50,000 shares of Arteris, Inc. common stock on 11/10/2025 coded as S (open-market sale).
Was the sale under a 10b5-1 plan?
Yes. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2025.
What is the insider’s relationship to Arteris (AIP)?
The reporting person is a Director.